Eric Dobmeier, President, CEO at CHINOOK THERAPEUTICS, INC. (KDNY), bought 5,000 shares at $13.03 ($65K) on 2022-05-25, disclosed to the SEC on 2022-05-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| KDNY | SELL | 2023-02-15 | $385K | — | Filing → |
| KDNY | SELL | 2023-02-01 | $993K | — | Filing → |
| KDNY | SELL | 2022-12-02 | $669K | — | Filing → |